Context: Dipeptidyl peptidase 4 (CD26/DPP4) is expressed on blood T cells and also circulates in a soluble form (sCD26/DPP4).Objective: We aimed to evaluate blood T cell and circulating CD26/DPP4 and its association with metabolic parameters in patients with type 2 diabetes mellitus (T2DM).Designs: We measured CD26/DPP4 expression (percentage of CD26+ cells using flow cytometry) on CD4+ and CD8+ T cells, serum CD26/DPP4 level and activity, and various metabolic parameters in T2DM patients not on DPP4 inhibitor therapy (n = 148). Nondiabetic subjects (n = 50) were included as a control group.Results: Compared with the healthy controls, CD26/DPP4 expression on CD4+ T cells and CD8+ T cells was higher in T2DM patients. Serum CD26/DPP4 levels and enzymatic activities were also higher in patients with T2DM than in the control group only when metformin and/or thiazolidinedione-treated T2DM patients were excluded; metformin and/or thiazolidinedione-treated T2DM patients had lower values compared with other T2DM patients. Various parameters in T2DM patients were related to CD26/DPP4 expression on the T cells (hemoglobin A1c), serum sCD26/DPP4 (hemoglobin A1c and insulin resistance assessed by updated homeostasis model assessment), and serum CD26/DPP4 activity (insulin resistance assessed by updated homeostasis model assessment, γ-glutamyl transferase, and alanine aminotransferase) by multivariate analyses. After active glucose control for 12 weeks in drug-naive T2DM patients (n = 50), CD26/DPP4 expression on blood T cells was significantly decreased.Conclusions: Our results suggest that the CD26/DPP4 level on blood T cells was associated with glucose control status in patients with T2DM.

Gyu Ri Kim, Ph.D., Eun-Young Kim, Ph.D., Si Hyun Kim, Ph.D., Hae Kyung Lee, M.D., Jaehyeon Lee, M.D., Jong Hee Shin, M.D., Young Ree Kim, M.D., Sae Am Song, M.D., Joseph Jeong, M.D., Young Uh, M.D., Yu Kyung Kim, M.D., Dongeun Yong, M.D., Hyun Soo Kim, M.D., Sunjoo Kim, M.D., Young Ah Kim, M.D., Kyeong Seob Shin, M.D., Seok Hoon Jeong, M.D., Namhee Ryoo, M.D., and Jeong Hwan Shin, M.D.. Ann Lab Med 2023;43:45-54. https://doi.org/10.3343/alm.2023.43.1.45

Chung HS, et al. J Korean Med Sci. 2013 Jan;28(1):62-66. https://doi.org/10.3346/jkms.2013.28.1.62

Park DC, et al. Ann Lab Med. 2019 Nov;39(6):537-544. https://doi.org/10.3343/alm.2019.39.6.537

Park SY, et al. Infect Chemother. 2024 Aug;56:e35. https://doi.org/10.3947/ic.2024.0038